                               SEQUENCE LISTING

<110> HELIX NANOTECHNOLOGIES, INC.
 
<120> MODIFIED RIBONUCLEIC ACIDS AND USES THEREOF

<130> 2012611-0038

<140> PCT/US2022/027721
<141> 2022-05-04

<150> 63/273,031
<151> 2021-10-28

<150> 63/185,925
<151> 2021-05-07

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 78
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
cttgttcttt ttgcagaagc tcagaataaa cgctcaactt tggccaccat ggaagatgcc       60

aaaaacatta agaagggc                                                     78


<210> 2
<211> 157
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
agaatgtgaa gaaactttct ttttattagg agcagatacg aatggctaca ttttggggga       60

caacattttg taaagtgtaa gttggtatta tgtagcttag agactccatt cgggtgttct      120

tgaggctggt ctatcattac acggcgatct tgccgcc                               157


<210> 3
<211> 45
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
gaatttaata cgactcacta taaggcttgt tctttttgca gaagc                       45


<210> 4
<211> 149
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt       60

tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt      120

agaatgtgaa gaaactttct ttttattag                                        149


